Genomic marker predicts anti-PD-1 response in several cancer

Genomic marker predicts anti-PD-1 response in several cancer

A phase II stufy identifies the first genmic marker MMR (MisMatch Repair) deficiency to predict response to pembrolizumab... Dr Dung T Le, SKCC center, Baltimore